Robert A. Sandhaus, MD, PhD, FCCP, Clinical Director, Alpha-1 Foundation, gave his presentation on COVID-19 Vaccines at the February 27, 2021 Virtual Alpha-1 Education Day.
Miriam O’Day, President & CEO, Alpha-1 Foundation, gave her presentation on the Alpha-1 Foundation’s Advocacy Updates at the February 27, 2021 Virtual Alpha-1 Education Day.
Miriam O’Day, President & CEO, Alpha-1 Foundation, and Jeanine D’Armiento, MD, PhD, Chair of the Board of
Directors, Alpha-1 Foundation, gave their presentations on the 2021 Alpha-1 Foundation Plans and a Research Registry Updateat the February 27, 2021 Virtual Alpha-1 Education Day.
Philip Rosenthal, MD, Professor of Pediatrics and Surgery, Director of Pediatric Hepatology Research, University of California, San Francisco, gave his presentation on Alpha-1 Pediatric Liver Disease at the February 27, 2021 Virtual Alpha-1 Education Day.
Alan Barker, MD, Professor of Medicine, Division of Pulmonary and Critical Care Medicine, School of Medicine, gave his presentation on Alpha-1 Pediatric Liver Disease at the February 27, 2021 Virtual Alpha-1 Education Day.
Jill Pollander, RN, MSN, Director of Patient Services, National Organization for Rare Disorders, gave her presentation on Rare Diseases at the February 27, 2021 Virtual Alpha-1 Education Day.
Richard Lovrich leads the conversation about the 20 tough Alpha-1 words. Within the virtual world, Alphas are invited to join the scientific workshops that are hosted by the Alpha-1 Foundation and other organizations. These discussions often bring up many new words for the attendees. Join Dr. Sandy Sandhaus, the Clinical Director for the Alpha-1 Foundation, for this podcast as he explains these tough words. Everyone will learn something new from this episode! Thank you Chelsea Boring, Lisa Kosak, Fred Walsh, and Bart Flook!
Jeanine D’Armiento, MD, PhD, Chair of the Board of Directors, Alpha-1 Foundation, delivered the Alpha-1 State of the Union on Thursday, January 21, 2021. Miriam O’Day, President & CEO of the Alpha-1 Foundation, joined Dr. D’Armiento for an audience question and answer session at the end of the presentation.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
